Sertraline, Buscopan for a 73-year old man - from FDA reports

A study for a 73 year old man who takes Sertraline, Buscopan - from FDA reports

7 males aged 73 (±5) who take the same drugs are studied. This is a personalized study for a 73 year old male patient who has Irritable Bowel Syndrome. The study is created by eHealthMe based on reports from FDA.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Peer to Peer mobile support

Peer support for this study is available on our Ginger Health app. It's free, anonymous and secure. The app is ideal for people taking multiple medications or having multiple conditions.

On Feb, 10, 2019

7 males aged 73 (±5) who take Sertraline, Buscopan are studied.

Number of reports submitted per year:

Sertraline, Buscopan for a 73-year old man.

Information of the patient in this study:

Age: 73
Gender: male
Conditions: Irritable Bowel Syndrome
Drugs taken:
- Sertraline (sertraline hydrochloride)
- Buscopan (hyoscine butylbromide)

eHealthMe real world results:

Most common drug interactions over time

< 1 month:

Haemorrhagic disorder (bleeding disorder)
Haemorrhage (bleeding)
C-reactive protein increased
Activated partial thromboplastin time shortened
White blood cell count decreased
Von willebrand's factor activity increased
Haemoglobin decreased
Protein total decreased
Haematocrit decreased
Red blood cell count decreased

1 - 6 months:

n/a

6 - 12 months:

Haemorrhagic disorder (bleeding disorder)
Haemorrhage (bleeding)
C-reactive protein increased
Activated partial thromboplastin time shortened
White blood cell count decreased
Von willebrand's factor activity increased
Haemoglobin decreased
Protein total decreased
Haematocrit decreased
Red blood cell count decreased

1 - 2 years:

n/a

2 - 5 years:

n/a

5 - 10 years:

n/a

10+ years:

n/a

not specified:

Breathing - slowed or stopped
Malaise (a feeling of general discomfort or uneasiness)
Enteritis (inflammation of the small intestine)
Appetite - decreased (decreased appetite occurs when you have a reduced desire to eat)

Top conditions involved for these people *:

Respiratory Tract Infection : 1 person, 14.29%
Pain : 1 person, 14.29%
Multiple Myeloma (cancer of the plasma cells): 1 person, 14.29%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 14.29%
Hypoalbuminaemia (levels of albumin in blood serum are abnormally low): 1 person, 14.29%
Gastric Ph Decreased : 1 person, 14.29%
Fever : 1 person, 14.29%
Enteritis (inflammation of the small intestine): 1 person, 14.29%
Dyslipidaemia (abnormal amount of lipids): 1 person, 14.29%
Dry Eyes (lack of adequate tears): 1 person, 14.29%

Top co-used drugs for these people *:

* Some reports may have incomplete information.

You are not alone:

What are the drugs?

Sertraline has active ingredients of sertraline hydrochloride. It is often used in depression. (latest outcomes from Sertraline 73,267 users)
Buscopan has active ingredients of hyoscine butylbromide. (latest outcomes from Buscopan 2,989 users)

What are the conditions?

Irritable bowel syndrome can be treated by Bentyl, Dicyclomine hydrochloride, Amitiza, Mebeverine hydrochloride, Linzess (latest reports from 30,074 Irritable bowel syndrome patients)

Related studies:

Sertraline and Buscopan drug interaction (80 reports)

Related publications that referenced our studies

Izgi C, Erdem G, Mansuroglu D, Kurtoglu N, Kara M, Gunesdogdu F, "Severe hypokalemia probably associated with sertraline use", Annals of Pharmacotherapy, 2014 Jan .

FDA reports used in this study

Want to find out more about the FDA reports used in the study? You can request them from FDA.

Recent updates

Recent general studies

Recent personal studies

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.